Yunguang Li
State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].
Journal: Cancer letters
Published: February 06, 2026
A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy.
Journal: Cell stem cell
Published: June 12, 2024
Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients.
Journal: Nature communications
Published: January 21, 2024
Clinical functional proteomics of intercellular signalling in pancreatic cancer.
Journal: Nature
Published: July 21, 2023
Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.
Journal: Cell reports. Medicine
Published: February 23, 2023
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.
Journal: Cell reports. Medicine
Published: January 03, 2023
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
Journal: Cancer cell
Published: February 08, 2022
Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide.
Journal: Nature communications
Published: September 16, 2020
Organoid technology for tissue engineering.
Journal: Journal of molecular cell biology
Published: October 26, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026